Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abbreviated, absorption, advisory, Alnylam, ancestry, ANDA, authoritative, automatically, Bayer, bigger, bioavailability, biosimilar, BLA, Brooklyn, budget, Campath, chemistry, clear, compulsory, Concurrent, consent, corroborated, decentralized, dexamethasone, disgorgement, dispersed, disputed, dissemination, distressed, DNA, Doctor, dossier, draft, drafted, easier, Elixir, endpoint, engineered, essential, ethically, evenly, exceeding, excretion, exit, export, false, FAS, FDAAA, FDCA, final, finalize, formulary, FSP, geographically, greatly, gregory, growth, heading, IGN, impossible, indirectly, input, insensitive, Interactive, interfering, invalidating, invalidity, ion, IRB, irreversible, Judiciary, lawfully, leaflet, led, lenalidomide, lost, MBC, MCC, MD, melanoma, member, methodology, misleading, MMA, moiety, morbidity, mutually, necessarily, newly, nonfinancial, Obama, outlook, outpatient, overlap, packed, parent, passage, payable, Payload, pediatric, perry, Peter, Pfizer, pharmacoeconomic, pharmacy, poor, postmarket, PREA, preliminarily, procedure, pure, purity, ratio, recognizable, recurred, recurring, regimen, registry, reinterpreted, requisite, restitution, restoration, resubmitted, Revlimid, route, sampling, Senate, Similarly, SMCC, stability, stably, statutory, stipulated, stream, strength, strictly, subpopulation, sunset, supplement, surgery, surrogate, surveillance, tier, Transkaryotic, unannounced, undergo, undertaken, unexpected, Union, unique, unobservable, unrecognizable, user, Vectibix, waiver
Removed:
acute, afflicted, assumed, begun, biotech, CanAg, CDER, choose, colorectal, comparative, conclusion, conform, continual, convertible, demonstrated, desired, executed, expiring, gastric, gastrointestinal, improve, initiated, leukemia, Mitchel, MTD, myeloid, notified, pancreatic, paper, pattern, preliminary, principle, Prodrug, profile, proof, qualify, question, receptor, recordkeeping, recoverable, reimbursable, relapsed, repeat, stable, stimulation, stringently, tolerability, tumor, understand, utilizing, weekly
Filing tables
Filing exhibits
Related press release
IMGN similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-3 Nos. 333-144488 and 333-152502 and Form S-8 Nos. 333-47543, 333-53292, 333-75372, 333-75374, 333-138713, 333-147738 and 333-155540) of ImmunoGen, Inc. and in the related Prospectuses of our reports dated August 28, 2009, with respect to the consolidated financial statements and schedule of ImmunoGen, Inc. and the effectiveness of internal control over financial reporting of ImmunoGen, Inc., included in the Annual Report (Form 10-K) for the year ended June 30, 2009.
/s/ERNST &YOUNG LLP |
Boston, Massachusetts
August 28, 2009